Ocugen Stock Quote OCGN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.94

Bid

1.91

Ask

1.94

Volume

6,471,250

1.8601 Day's Range 2.025

0.345 52 Week Range 2.105

Market Cap

487.355M

Previous Close

1.98

Open

1.97

Last Trade

200

1.94

(formt)

Last Trade Time

Financial Volume

$ 12,515,326

VWAP

1.934

Average Volume (3m)

9,505,143

Shares Outstanding

256,502,434

Dividend Yield

PE Ratio

-7.73

Earnings Per Share (EPS)

-0.25

Revenue

6.04M

Net Profit

-63.08M

Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal... Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Ortho,prosth,surg Appl,suply

Website

ocugen.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Ocugen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker OCGN. The last closing price for Ocugen was $1.98. Over the last year, Ocugen shares have traded in a share price range of $ 0.345 to $ 2.105.

Ocugen currently has 256,502,434 shares outstanding. The market capitalization of Ocugen is $487.35 million. Ocugen has a price to earnings ratio (PE ratio) of -7.73.

Form PRE 14A - Other preliminary proxy statements

Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy

MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.27	16.1676646707	1.67	2.06	1.54	9741435	1.8496792	CS
4	0.65	50.3875968992	1.29	2.06	1.11	7615735	1.55099863	CS
12	0.99	104.210526316	0.95	2.105	0.7425	9505143	1.47588016	CS
26	1.551	398.714652956	0.389	2.105	0.36	6777343	1.22504752	CS
52	1.24	177.142857143	0.7	2.105	0.345	5668630	0.92972425	CS
156	-6.8	-77.8032036613	8.74	17.65	0.345	10844545	5.4437362	CS
260	-1.3	-40.1234567901	3.24	18.77	0.17	17648786	5.42537344	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.68M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.23M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.35M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.74B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.51M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.25M